Introduction No human civilization—whether large or small, modern or traditional—has ever survived without collectively ...

Finally, Kepler Capital Markets upgraded shares of ... buying an additional 40,313 shares during the period. Finally, Renaissance Technologies LLC grew its position in Novo Nordisk A/S by 1.5 ...

Life is tenacious and the universe is vast, so some are confident that extraterrestrial life is hiding out there. These worlds are the top contenders.

Few products in the realm of dietary supplements capture the attention and interest of consumers quite like Renaissance.Designed specifically to support male sexual health, Renaissance is a unique ...

The idea of artificial general intelligence captivated thinkers for decades before it came anywhere near being realized. The concept still conjures popular visions out of science fiction, from C ...

Former President Ranil Wickremesinghe’s recent combative ‘Head-to-Head’ interview with British-American Mehdi Hasan on Al ...

Novo Nordisk A/S researches, develops, manufactures, and sells pharmaceutical products. The company operates through Rare Disease and Obesity & Diabetes care segments. Regardless of a 39% decline ...

The company’s share price rebounded after Kepler Cheuvreux upgraded NVO citing its effective obesity/diabetes medications. The financial services firm raised its rating on the company from Hold ...